Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Cytokine and immunoglobulin isotype profiles during CP7_E2alf vaccination against a challenge with the highly virulent Koslov strain of classical swine fever virus.

Renson P, Le Dimna M, Gabriel C, Levai R, Blome S, Kulcsar G, Koenen F, Le Potier MF.

Res Vet Sci. 2014 Apr;96(2):389-95. doi: 10.1016/j.rvsc.2014.01.002.

PMID:
24530018
2.

CP7_E2alf oral vaccination confers partial protection against early classical swine fever virus challenge and interferes with pathogeny-related cytokine responses.

Renson P, Le Dimna M, Keranflech A, Cariolet R, Koenen F, Le Potier MF.

Vet Res. 2013 Feb 11;44:9. doi: 10.1186/1297-9716-44-9.

3.

Efficacy of marker vaccine candidate CP7_E2alf against challenge with classical swine fever virus isolates of different genotypes.

Blome S, Gabriel C, Schmeiser S, Meyer D, Meindl-Böhmer A, Koenen F, Beer M.

Vet Microbiol. 2014 Feb 21;169(1-2):8-17. doi: 10.1016/j.vetmic.2013.12.002.

PMID:
24411658
4.

Efficacy of marker vaccine candidate CP7_E2alf in piglets with maternally derived C-strain antibodies.

Rangelova D, Nielsen J, Strandbygaard B, Koenen F, Blome S, Uttenthal A.

Vaccine. 2012 Oct 5;30(45):6376-81. doi: 10.1016/j.vaccine.2012.08.035.

PMID:
22939909
5.

Efficacy of CSF vaccine CP7_E2alf in piglets with maternally derived antibodies.

Eblé PL, Quak S, Geurts Y, Moonen-Leusen HW, Loeffen WL.

Vet Microbiol. 2014 Nov 7;174(1-2):27-38. doi: 10.1016/j.vetmic.2014.08.030.

PMID:
25265929
6.

Efficacy of chimeric Pestivirus vaccine candidates against classical swine fever: protection and DIVA characteristics.

Eblé PL, Geurts Y, Quak S, Moonen-Leusen HW, Blome S, Hofmann MA, Koenen F, Beer M, Loeffen WL.

Vet Microbiol. 2013 Mar 23;162(2-4):437-46. doi: 10.1016/j.vetmic.2012.10.030.

PMID:
23238022
7.
8.

Towards licensing of CP7_E2alf as marker vaccine against classical swine fever-Duration of immunity.

Gabriel C, Blome S, Urniza A, Juanola S, Koenen F, Beer M.

Vaccine. 2012 Apr 19;30(19):2928-36. doi: 10.1016/j.vaccine.2012.02.065.

PMID:
22406108
9.

Comparative evaluation of live marker vaccine candidates "CP7_E2alf" and "flc11" along with C-strain "Riems" after oral vaccination.

Blome S, Aebischer A, Lange E, Hofmann M, Leifer I, Loeffen W, Koenen F, Beer M.

Vet Microbiol. 2012 Jul 6;158(1-2):42-59. doi: 10.1016/j.vetmic.2012.02.015.

PMID:
22397931
10.

DIVA vaccine properties of the live chimeric pestivirus strain CP7_E2gif.

von Rosen T, Rangelova D, Nielsen J, Rasmussen TB, Uttenthal Å.

Vet Microbiol. 2014 Jun 4;170(3-4):224-31. doi: 10.1016/j.vetmic.2014.02.018.

PMID:
24629779
11.
12.

Evaluation of an Erns-based enzyme-linked immunosorbent assay to distinguish Classical swine fever virus-infected pigs from pigs vaccinated with CP7_E2alf.

Pannhorst K, Fröhlich A, Staubach C, Meyer D, Blome S, Becher P.

J Vet Diagn Invest. 2015 Jul;27(4):449-60. doi: 10.1177/1040638715592446.

PMID:
26179095
13.

Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization.

Leifer I, Lange E, Reimann I, Blome S, Juanola S, Duran JP, Beer M.

Vaccine. 2009 Nov 5;27(47):6522-9. doi: 10.1016/j.vaccine.2009.08.057.

PMID:
19732859
14.
15.

First assessment of classical swine fever marker vaccine candidate CP7_E2alf for oral immunization of wild boar under field conditions.

Feliziani F, Blome S, Petrini S, Giammarioli M, Iscaro C, Severi G, Convito L, Pietschmann J, Beer M, De Mia GM.

Vaccine. 2014 Apr 11;32(18):2050-5. doi: 10.1016/j.vaccine.2014.02.006.

PMID:
24565752
16.

The correlation of virus-specific interferon-gamma production and protection against classical swine fever virus infection.

Suradhat S, Intrakamhaeng M, Damrongwatanapokin S.

Vet Immunol Immunopathol. 2001 Dec;83(3-4):177-89.

PMID:
11730928
17.
18.

Characterisation of virus-specific peripheral blood cell cytokine responses following vaccination or infection with classical swine fever viruses.

Graham SP, Everett HE, Johns HL, Haines FJ, La Rocca SA, Khatri M, Wright IK, Drew T, Crooke HR.

Vet Microbiol. 2010 Apr 21;142(1-2):34-40. doi: 10.1016/j.vetmic.2009.09.040.

PMID:
19854006
19.

Pre-registration efficacy study of a novel marker vaccine against classical swine fever on Maternally Derived Antibody negative (MDA-) target animals.

Lévai R, Barna T, Fábián K, Blome S, Belák K, Bálint Á, Koenen F, Kulcsár G, Farsang A.

Biologicals. 2015 Mar;43(2):92-9. doi: 10.1016/j.biologicals.2014.12.004.

PMID:
25637578
20.

Vaccinology of classical swine fever: from lab to field.

van Oirschot JT.

Vet Microbiol. 2003 Nov 7;96(4):367-84. Review.

PMID:
14599784
Items per page

Supplemental Content

Support Center